Tremor and Other Hyperkinetic Movements
Scope & Guideline
Advancing knowledge on hyperkinetic movements for a healthier tomorrow.
Introduction
Aims and Scopes
- Study of Tremor Phenomenology:
The journal emphasizes detailed investigations into different types of tremors, including essential tremor, dystonic tremor, and other movement disorders, aiming to enhance clinical understanding and management. - Clinical and Genetic Research:
There is a strong focus on the intersection of clinical presentations and genetic factors, exploring how genetic variants contribute to hyperkinetic movement disorders and their phenotypic expression. - Innovative Therapeutic Approaches:
The journal covers various therapeutic interventions, including pharmacological treatments, deep brain stimulation, and novel therapies like transcutaneous afferent patterned stimulation, highlighting their effectiveness in managing movement disorders. - Patient-Centric Outcomes:
Research often focuses on patient-reported outcomes and quality of life measures, assessing how different treatments impact daily living and overall well-being in patients with movement disorders. - Multidisciplinary Collaboration:
The journal promotes collaboration between neurologists, geneticists, physiotherapists, and other healthcare professionals to address the complexities of hyperkinetic movement disorders.
Trending and Emerging
- Integration of Genetic Testing:
There is a growing trend towards integrating genetic testing and analysis into the clinical management of movement disorders, facilitating personalized treatment plans based on genetic profiles. - Use of Digital Health Technologies:
Recent publications highlight the use of digital health technologies, such as smartphone applications for tracking symptoms and facilitating telemedicine consultations, as innovative approaches to managing tremors. - Focus on Functional Movement Disorders:
There is an increasing emphasis on understanding and treating functional movement disorders, reflecting a shift in clinical interest and the need for multidisciplinary approaches in management. - Longitudinal Studies on Treatment Outcomes:
Emerging trends include longitudinal studies examining the long-term effects of various treatments on tremor and hyperkinetic disorders, providing valuable insights into the sustainability of therapeutic benefits. - Exploration of Neuroinflammatory Mechanisms:
Research into the neuroinflammatory mechanisms underlying movement disorders is gaining traction, suggesting a potential area for therapeutic intervention and novel treatment strategies.
Declining or Waning
- Historical Perspectives on Treatment:
There has been a noticeable decrease in papers solely focused on historical treatment approaches for movement disorders, reflecting a shift towards more contemporary and evidence-based practices. - Non-Pharmacological Interventions:
Research on non-pharmacological interventions, such as behavioral therapies for movement disorders, appears to be waning, possibly due to a growing emphasis on pharmacological and surgical options. - General Epidemiological Studies:
While epidemiological studies are important, there seems to be a gradual reduction in broad epidemiological analyses, with more emphasis now on specific genetic or clinical characteristics of movement disorders. - Aging and Movement Disorders:
The exploration of aging-related movement disorders has diminished, which may be attributed to a more focused approach on younger populations or specific genetic conditions.
Similar Journals
Neurodegenerative Diseases
Pioneering insights into the future of neurology.Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.
Practical Radiation Oncology
Advancing the Frontiers of Radiation OncologyPractical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.
Journal of Neuromuscular Diseases
Connecting minds to revolutionize neuromuscular care.Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.
Epilepsi
Fostering breakthroughs in epilepsy management and care.Epilepsi is an esteemed academic journal dedicated to advancing the field of epilepsy research and treatment, published by KARE PUBL. With its open access model established since 2017, the journal ensures that vital research findings are easily accessible to a global audience, thereby fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students. The journal focuses on a comprehensive range of topics within neurology, including clinical studies, therapeutic advancements, and innovative approaches to epilepsy management. Located in Istanbul, Turkey, Epilepsi aims to bridge the gap between research and practice, enhancing understanding and patient care for individuals affected by epilepsy. Its commitment to high-quality, peer-reviewed content makes it a significant resource for anyone involved in epilepsy research or clinical practice.
INTERNATIONAL JOURNAL OF HEMATOLOGY
Advancing the Science of Blood HealthThe INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.
Journal of Movement Disorders
Elevating understanding, enhancing treatment in movement disorders.The Journal of Movement Disorders, published by the Korean Movement Disorders Society, is a premier open access journal dedicated to advancing the field of neurology with a specific focus on movement disorders. Established in 2008 and indexed with ISSN 2005-940X and E-ISSN 2093-4939, this journal plays a vital role in disseminating high-quality research and clinical insights to a global audience. With an impressive Q2 ranking in both Neurology and Clinical Neurology categories for 2023, the journal continues to feature innovative research articles that contribute to better understanding and management of various movement disorders. Ranked 104th out of 400 in Clinical Neurology and 54th out of 192 in Neuroscience, the Journal of Movement Disorders offers an essential platform for researchers, healthcare professionals, and students alike, fostering collaboration and knowledge exchange in a rapidly evolving field.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
Navigating the Evolving Landscape of Mental HealthFORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE is a pivotal journal in the fields of neurology, psychiatry, and related medical disciplines, published by GEORG THIEME VERLAG KG in Germany. With a history dating back to 1955, this journal has evolved to address the dynamic nature of neurological and psychiatric research, offering valuable insights and advancements in the field. Despite holding a Q4 category status in various medical domains according to the 2023 quartiles, the journal continues to foster academic discussion and engagement among researchers and clinicians alike. It serves as a vital platform for disseminating knowledge through original research articles, reviews, and clinical studies, making it an essential resource for professionals and students aiming to stay abreast of the latest developments in mental health and neurological science. Although the journal currently does not offer open access options, its contribution to the academic community is significant, helping to illuminate the intricate relationships between neurological disorders and psychiatric conditions.
PARKINSONISM & RELATED DISORDERS
Shaping the dialogue on neurodegenerative diseases.PARKINSONISM & RELATED DISORDERS, published by Elsevier Science Ltd, is a prominent peer-reviewed journal dedicated to advancing the understanding of Parkinson's disease and related neurodegenerative disorders. With an impact factor placing it in the Q2 category across multiple fields including Geriatrics and Gerontology and Neurology for 2023, this journal serves as a crucial platform for researchers, healthcare professionals, and students alike. Covering an array of topics from clinical trials to innovative therapeutic strategies, it aims to disseminate valuable insights that can improve patient care and outcomes. While it remains a subscription-based journal, its relevance is underscored by its consistent rankings in Scopus, where it ranks 105th in Clinical Neurology and 35th in Geriatrics and Gerontology. Authored by top scholars in the field, PARKINSONISM & RELATED DISORDERS continues to contribute significantly to the body of knowledge surrounding these debilitating conditions, facilitating the exchange of cutting-edge research and fostering collaboration within the scientific community.
npj Parkinsons Disease
Exploring innovative solutions for neurodegenerative disorders.npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
Advancing the Frontiers of NeurosurgerySTERREOTACTIC AND FUNCTIONAL NEUROSURGERY, published by KARGER, is a distinguished journal focusing on the evolving fields of neurosurgery and functional neurology. With its ISSN of 1011-6125 and E-ISSN of 1423-0372, this journal has been at the forefront of publishing innovative research since its inception in 1938, securing a prominent position within the scientific community through its commitment to high-quality peer-reviewed articles. As of 2023, it ranks in the Q3 quartile for Clinical Neurology and Q2 for Surgery, reflecting its impactful contributions and relevance to current medical practice. Researchers and practitioners alike will benefit from the journal’s exploration of novel techniques, therapeutic advancements, and clinical outcomes in stereotactic and functional neurosurgery, making it an invaluable resource for those aiming to stay abreast of the latest developments in this dynamic field. Although it does not currently offer open access, readers can access its content via institutional subscriptions, ensuring widespread dissemination of critical research findings aimed at improving patient care and advancing surgical methodologies.